Approval of the First CRISPR-Cas9 Gene Editing Therapy for Sickle Cell Disease
Release Date: 10/17/2024
Clinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outlineClinical Chemistry Podcast
info_outline
No Description for this episode